FDA Inspection 1226104 — Mayo Clinic Hospital - Rochester Methodist Campus Division of Transfusion Medicine
The FDA completed an inspection of Mayo Clinic Hospital - Rochester Methodist Campus Division of Transfusion Medicine on November 16, 2023 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rochester, MN (United States)